Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct;60(4):414-9.
doi: 10.1002/ana.20960.

A heterozygous effect for PINK1 mutations in Parkinson's disease?

Patrick M Abou-Sleiman  1 , Miratul M K Muqit, Neil Q McDonald, Yan Xiang Yang, Sonia Gandhi, Daniel G Healy, Kirsten Harvey, Robert J Harvey, Emma Deas, Kailash Bhatia, Niall Quinn, Andrew Lees, David S Latchman, Nicholas W Wood
Affiliations

A heterozygous effect for PINK1 mutations in Parkinson's disease?

Patrick M Abou-Sleiman et al. Ann Neurol. 2006 Oct.

Abstract

Objective: To investigate the significance of PINK1 mutations in sporadic Parkinson's disease (PD).

Methods: We determined the frequency of PINK1 mutations by direct sequencing in a large series of PD patients with apparently sporadic disease (n = 768).

Results: Twelve heterozygous mutations were identified, nine in PD patients and three in control subjects.

Interpretation: Given the difficulty in interpreting the pathogenic significance of the heterozygous mutations that have already been reported in parkin and DJ-1, we first determined the frequency of heterozygous PINK1 mutations in the general population by sequencing a large number of control subjects (n = 768), then subsequently assessed their functional significance by examining their effects on stress-induced alterations to the mitochondrial membrane potential (DeltaPsim). We demonstrate an enrichment of heterozygous mutations in sporadic PD patients compared with matched control subjects (1.2% in PD vs 0.4% in control subjects). Furthermore, we show that they adversely affect DeltaPsim in a similar way to the familial G309D mutation. Although it remains difficult to conclusively demonstrate the pathogenicity of heterozygous mutations, the results of this study and the previously reported subclinical nigrostriatal dysfunction in carriers of heterozygous PINK1 mutations suggest the possibility that these heterozygous mutations are a significant risk factor in the development of later onset PD.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

LinkOut - more resources